|Study Description:||The goal of this clinical research study is to find the highest tolerable dose |
of the combination of dasatinib and crizotinib that can be given to patients
with advanced cancer. The safety of this drug combination will also be
Dasatinib is designed to block certain proteins from causing cancer cells to
grow out of control. This may cause the cancer cells to die.
Crizotinib is designed to block certain abnormal genes found in cancer cells.
This may cause the cancer cells to die.